052-CAR T-Cell Therapy for Pediatric Central Nervous System
This paper provides an overview of the challenges and advancements in CAR T-cell therapy for pediatric central nervous system (CNS) tumors, which are a leading cause of cancer-related death in children. It discusses the feasibility and early efficacy of CAR T-cell trials, while also highlighting significant obstacles such as limited trafficking to tumors, the immunosuppressive tumor microenvironment, and tumor heterogeneity. The article explores various strategies to overcome these barriers, including optimized delivery methods like locoregional infusion, the identification of suitable tumor…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.